Toxicity of amphetamines: an update

M Carvalho, H Carmo, VM Costa, JP Capela… - Archives of …, 2012 - Springer
Amphetamines represent a class of psychotropic compounds, widely abused for their
stimulant, euphoric, anorectic, and, in some cases, emphathogenic, entactogenic, and …

Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms

R Moratalla, A Khairnar, N Simola, N Granado… - Progress in …, 2017 - Elsevier
Amphetamine-related drugs, such as 3, 4-methylenedioxymethamphetamine (MDMA) and
methamphetamine (METH), are popular recreational psychostimulants. Several preclinical …

Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release

JPM Finberg - Pharmacology & therapeutics, 2014 - Elsevier
Inhibitors of monoamine oxidase (MAO) were initially used in medicine following the
discovery of their antidepressant action. Subsequently their ability to potentiate the effects of …

Amphetamine toxicities: classical and emerging mechanisms

BK Yamamoto, A Moszczynska… - Annals of the New York …, 2010 - Wiley Online Library
The drugs of abuse, methamphetamine and MDMA, produce long‐term decreases in
markers of biogenic amine neurotransmission. These decreases have been traditionally …

Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview

JP Capela, H Carmo, F Remião, ML Bastos… - Molecular …, 2009 - Springer
Abstract “Ecstasy”[(±)-3, 4-methylenedioxymethamphetamine, MDMA, XTC, X, E] is a
psychoactive recreational hallucinogenic substance and a major worldwide drug of abuse …

Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs

T Cunha-Oliveira, AC Rego, CR Oliveira - Brain research reviews, 2008 - Elsevier
Substance abuse and addiction are the most costly of all the neuropsychiatric disorders. In
the last decades, much progress has been achieved in understanding the effects of the …

[HTML][HTML] Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics

D Rudin, ME Liechti, D Luethi - Experimental neurology, 2021 - Elsevier
New psychoactive stimulants and psychedelics continue to play an important role on the
illicit new psychoactive substance (NPS) market. Designer stimulants and psychedelics both …

The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and d-amphetamine

T Steinkellner, M Freissmuth, HH Sitte, T Montgomery - 2011 - degruyter.com
Abstract Amphetamine ('Speed'), methamphetamine ('Ice') and its congener 3, 4-
methylenedioxymethamphetamine (MDMA;'Ecstasy') are illicit drugs abused worldwide for …

Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression

M Naoi, P Riederer, W Maruyama - Journal of Neural Transmission, 2016 - Springer
Monoamine oxidase types A and B (MAO-A, MAO-B) regulate the levels of monoamine
neurotransmitters in the brain, and their dysfunction may be involved in the pathogenesis …

Neuroprotective activities of curcumin and quercetin with potential relevance to mitochondrial dysfunction induced by oxaliplatin

M Waseem, S Parvez - Protoplasma, 2016 - Springer
Peripheral neurotoxicity is one of the serious dose-limiting side effects of oxaliplatin (Oxa)
when used in the treatment of malignant conditions. It is documented that it elicits major side …